Marini Cecilia, Cossu Vanessa, Bauckneht Matteo, Carta Sonia, Lanfranchi Francesco, D'Amico Francesca, Ravera Silvia, Orengo Anna Maria, Ghiggi Chiara, Ballerini Filippo, Durando Paolo, Chiesa Sabrina, Miceli Alberto, Donegani Maria Isabella, Morbelli Silvia, Bruno Silvia, Sambuceti Gianmario
CNR, Institute of Molecular Bioimaging and Physiology (IBFM), 20054 Milan, Italy.
IRCCS, Ospedale Policlinico San Martino, 16132 Genoa, Italy.
Antioxidants (Basel). 2022 Apr 11;11(4):762. doi: 10.3390/antiox11040762.
The redox stress caused by Hodgkin's lymphoma (HL) also involves the peripheral blood mononucleated cells (PBMCs) even before chemotherapy. Here, we tested whether lymphocytes and monocytes show a different response to the increased mitochondrial generation of reactive oxygen species (ROS).
PBMCs, isolated from the blood of treatment-naïve HL patients and control subjects, underwent assessment of malondialdehyde content and enzymatic activity of both hexose- and glucose-6P dehydrogenase (H6PD and G6PD) as well as flow cytometric analysis of mitochondrial ROS content. These data were complemented by evaluating the uptake of the fluorescent glucose analogue 2-NBDG that is selectively stored within the endoplasmic reticulum (ER).
Malondialdehyde content was increased in the whole population of HL PBMCs. The oxidative damage matched an increased activity of G6PD, and even more of H6PD, that trigger the cytosolic and ER pentose phosphate pathways, respectively. At flow cytometry, the number of recovered viable cells was selectively decreased in HL lymphocytes that also showed a more pronounced increase in mitochondrial ROS generation and 2-NBDG uptake, with respect to monocytes.
PBMCs of HL patients display a selective mitochondrial and ER redox stress most evident in lymphocytes already before the exposure to chemotherapy toxicity.
霍奇金淋巴瘤(HL)引起的氧化还原应激甚至在化疗前就涉及外周血单核细胞(PBMC)。在此,我们测试了淋巴细胞和单核细胞对线粒体活性氧(ROS)生成增加是否表现出不同的反应。
从未经治疗的HL患者和对照受试者的血液中分离出PBMC,对丙二醛含量、己糖和葡萄糖-6-磷酸脱氢酶(H6PD和G6PD)的酶活性进行评估,并对线粒体ROS含量进行流式细胞术分析。通过评估选择性储存在内质网(ER)中的荧光葡萄糖类似物2-NBDG的摄取来补充这些数据。
HL患者PBMC的总体丙二醛含量增加。氧化损伤与G6PD活性增加相匹配,H6PD活性增加更明显,它们分别触发胞质和内质网磷酸戊糖途径。在流式细胞术中,HL淋巴细胞中回收的活细胞数量选择性减少,相对于单核细胞,HL淋巴细胞中线粒体ROS生成和2-NBDG摄取也有更明显的增加。
HL患者的PBMC在暴露于化疗毒性之前,就已在淋巴细胞中表现出最明显的选择性线粒体和内质网氧化还原应激。